Harold Bernstein, President, R&D & CMO at Maze Therapeutics, Inc. (MAZE), sold 10,295 shares at $26.38 ($270K) on 2026-09-02, disclosed to the SEC on 2026-09-04.
Open-market sale of $270k MAZE by President, R&D & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.38 | 4,481 | $118K | 43.8% |
| 2 | $27.12 | 625 | $17K | 6.3% |
| 3 | $25.78 | 59 | $2K | 0.6% |
| 4 | $26.01 | 5,130 | $133K | 49.4% |
| Total | $26.24 avg | 10,295 | $270K | 100% |
| Filing → |
| MAZE | SELL | 2026-09-03 | $426K | — | Filing → |
| MAZE | SELL | 2026-08-14 | $446K | — | Filing → |
| MAZE | SELL | 2026-07-02 | $437K | — | Filing → |